Clinical Trial

Alzheimer's Disease Research Center (ADRC) PET Component Study

Study acronym: ADRC PET
Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to further engage and characterize Alzheimer's Disease Research Center (ADRC) participants through additional research opportunities, particularly PET imaging. Amyloid and Tau PET imaging will be collected in 24 participants per year, for a total of 120 participants over five years. All participants will be followed longitudinally, including through potential transitions from normal aging to mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD).
Trial Details
NCT Number NCT07758660
Lead Sponsor Patrick Lao
Collaborators: National Institute on Aging (NIA)
Conditions Alzheimer Disease, Mild Cognitive Impairment (MCI), Dementia
Enrollment 120 participants
Start Date 2026-08-06
Primary Completion 2031-05-31 (estimated)
Study Completion 2033-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-11